HSL Mobile App 
52 week Low
1,080.00
1,080.00
52 week High
1,724.35
1,724.35
1673.40
Day low
1,659.15
1,659.15
Day high
1,700
1,700
1673.40
Prev Close
1,629.85
1,629.85
Open
1,637.80
1,637.80
6M return
38.96%
38.96%
1Y return
31.75%
31.75%
MCap(Rs. in Cr.)
34,578.87
34,578.87
Total Volume
4,02,440
4,02,440
Face Value : 10
Listed Since 06 Jan 2016
PE Ratio
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
P/E RATIO
44.10300
EPS
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
EPS
38.35
PRICE/BOOK
Price-to-book ratio is used to compared the company's current market price with its book value.
PRICE/BOOK
10.67
Deliverable
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
DELIVERABLES
30.65%
DIV YIELD.(%)
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
DIV YIELD.(%)
0.24
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
Resistance 1
1656.73
1656.73
Resistance 2
1683.62
1683.62
Support 1
1613.68
1613.68
Support 2
1597.52
1597.52
Moving Average
20 Days
1603.15
1603.15
50 Days
1450.30
1450.30
100 Days
1367.91
1367.91
200 Days
1307.28
1307.28
Growth in 3 years
Sales
35.58%
Sales Industry Avg
4.63%
PAT
130.80%
PAT Industry Avg
6.30%
35.58%
Sales Industry Avg
4.63%
PAT
130.80%
PAT Industry Avg
6.30%
| Dec 2024 ( in Cr.) | Sep 2024 ( in Cr.) | Jun 2024 ( in Cr.) | Mar 2024 ( in Cr.) | FY 2024 ( in Cr.) | |
|---|---|---|---|---|---|
| Sales | 1,366.68 | 1,400.01 | 1,340.95 | 1,279.42 | 5,018.25 |
| Gross Profit | 288.79 | 296.90 | 293.34 | 290.41 | 1,130.67 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 221.89 | 227.90 | 231.38 | 242.02 | 888.52 |
| Tax | 28.84 | 29.10 | 29.89 | 51.24 | 98.90 |
| Profit After Tax | 193.05 | 198.80 | 201.49 | 190.78 | 789.62 |
Growth in 3 years
Total Asset Growth
85.93%
Total Liabilities growth
103.90%
Reserves Change
108.63%
85.93%
Total Liabilities growth
103.90%
Reserves Change
108.63%
| Mar 2024 ( in Cr.) | Mar 2023 ( in Cr.) | Mar 2022 ( in Cr.) | Mar 2021 ( in Cr.) | Mar 2019 ( in Cr.) | |
|---|---|---|---|---|---|
| Share Capital | 204.36 | 204.36 | 204.36 | 204.36 | 204.36 |
| Reserves And Surplus | 2,679.32 | 1,927.02 | 1,284.27 | 915.92 | 876.77 |
| Investments | 844.16 | 251.86 | 132.38 | 120.34 | 17.42 |
| Total Debt | 1,626.69 | 884.18 | 723.43 | 825.64 | 813.47 |
| Total Liabilities | 4,511.78 | 3,016.61 | 2,212.79 | 1,946.46 | 1,895 |
| Total Assets | 4,245.69 | 2,990.51 | 2,283.50 | 2,094.01 | 1,973.07 |
25%
Dividend
Date:07 Jul 2023
Dividend Percentage:25
Dividend Type:Final
2023
40%
Dividend
Date:02 Aug 2024
Dividend Percentage:40
Dividend Type:Final
2024 2025
2026
Relative to Sensex rtn in 3 year
281.58%
Relative to Nifty rtn in 3 year
255.05%
Relative to top 3 MF rtn in 3 year
281.58%
Relative to Nifty rtn in 3 year
255.05%
Relative to top 3 MF rtn in 3 year
| 1 Year (%) | 2 Year (%) | 3 Year (%) | |
|---|---|---|---|
| Narayana Hrudaya | 32 | 125 | 131 |
| Bse Sensex | 6 | 34 | 34 |
| Nifty 50 | 7 | 39 | 37 |
| Nifty 500 | 7 | 50 | 46 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Narayana Hrudaya
1673.40 chg : 43.55 (2.67%)
1673.40 chg : 43.55 (2.67%)
Max Healthcare
1129.40 chg : 6.85 (0.61%)
1129.40 chg : 6.85 (0.61%)
Apollo Hospitals
6492.05 chg : -27.75 (-0.43%)
6492.05 chg : -27.75 (-0.43%)
Fortis Health.
671.80 chg : 26.10 (4.04%)
671.80 chg : 26.10 (4.04%)
Global Health
1213.85 chg : -6.30 (-0.52%)
1213.85 chg : -6.30 (-0.52%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
My investment would be worth 1,31,753.40 with a Gain of 31.75%
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
Institutional Reports 08 Feb 2022 7:06 AM
Astral: We maintain our REDUCE rating on Astral with a revised TP of INR 2,180/sh (34x its Dec-23E consolidated EBITDA, implying 53x P/E), owing to its expensive valuation. Weak demand in Q3FY22 pull..
Institutional Reports 13 Nov 2021 8:03 AM
Alkem Labs: Alkem’s Q2 revenue/EBITDA beat our estimates by 5%/14%, led by good growth in India and international markets. India business delivered a 26% YoY growth, led by strong volume-led recovery..
Institutional Reports 10 Aug 2021 7:00 AM
Shree Cement: We maintain our REDUCE rating on Shree Cement (SRCM) with an unchanged SOTP target price of INR 27,500/share (standalone cement business at 16.5x Jun’23E EBITDA and UAE business at 1x B..
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
D
2023 Dividend
Date:07 Jul 2023
Dividend Percentage:25
D
2024 Dividend
Date:02 Aug 2024
Dividend Percentage:40
2025
Our Research Analysis
As of today
__PERCENT__%
Target Achived
__PERCENT__%
Target Achived
This call still has potential to give significant positive returns
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
CMP : __CMP__
Target : __TARGET__
Stop Loss : __STOPLOSS__
Reco Price : __RECOPRICE__
Reco Date :__RECODATE__
Call Type :__CALLTYPE__
__Rationale__
__RECOTYPE__ __COMPANY_NAME__
|
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
Our View __RECOTYPE__
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
| No data available |
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
| Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
|---|---|---|---|
| No data available | |||
News
Stay tuned to the latest developments and happenings in the company.
Narayana Hrudayalaya consolidated net profit rises 2.62% in the December 2024 quarter
Net profit of Narayana Hrudayalaya rose 2.62% to Rs 192.94 crore in the quarter ended December 2024 as against Rs 188.02 crore during the previous qua....
15 Feb 2025 07:40Narayana Hrudayalaya to discuss results
Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live Ne....
08 Feb 2025 14:07Narayana Hrudayalaya announces infusion of USD 1.5 million in Cayman Integrated Healthcare
Narayana Hrudayalaya announced that Health City Cayman Islands (HCCI), a wholly owned overseas subsidiary of the Company has infused an amount....
07 Dec 2024 16:22Narayana Hrudayalaya consolidated net profit declines 12.34% in the September 2024 quarter
Net profit of Narayana Hrudayalaya declined 12.34% to Rs 198.63 crore in the quarter ended September 2024 as against Rs 226.58 crore during the previo....
02 Nov 2024 09:57Narayana Hrudayalaya to discuss results
Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 31 October 2024.Powered by Capital Market - Live New....
25 Oct 2024 10:44Narayana Hrudayalaya standalone net profit rises 9.46% in the June 2024 quarter
Net profit of Narayana Hrudayalaya rose 9.46% to Rs 86.41 crore in the quarter ended June 2024 as against Rs 78.94 crore during the previous quarter e....
03 Aug 2024 07:35__heading__
Published on __date__ at __time__
__description__
